Fourteen patients were included, representing 5.7% of the total neurosarcoidosis cohort, including 5 patients with symptomatic trigeminal neuropathy and 9 patients with asymptomatic radiographic trigeminal nerve involvement. Average age of neurosarcoidosis onset was 48.0 years, and most were African American (11/14, 78.6%) and male (8/14, 57.1%). All symptomatic patients presented chronically with unilateral symptoms (numbness in the trigeminal distribution in 5/14, 35.7%, and trigeminal neuralgia in 2/14, 14.3%), either in isolation (2/5, 40%) or as part of a greater constellation of neurologic symptoms (3/5, 60.0%). The most commonly affected trigeminal structures on contrasted MRI were the cisternal portion of the trigeminal nerve (9/14, 64.3%), Meckel’s cave (7/14, 50.0%), and the cavernous sinus (5/14, 35.7%). At least one routine CSF parameter was abnormal in 10/12 (83.3%) tested patients. Four symptomatic patients were treated with corticosteroids, with 3/4 (75.0%) experiencing complete resolution or partial symptomatic improvement. Twelve patients had follow-up MRIs after receiving treatment with trigeminal inflammation completely resolving in 9/12 (75.0%) and partially improving in 3/12 (25.0%). The average last mRS was 1.4 after an average follow-up period of 91.5 months.